The independent source for health policy research, polling, and news.
61-80 of 558 results
Amid falling birth rates and presidential approval numbers, the Department of Health and Human Services convened doctors, tech executives, and influencers to discuss women’s health. Panelists criticized reliance on birth control pills to treat health problems and encouraged doctors to talk with girls about whether they want to have babies.
HHS Secretary Robert F. Kennedy Jr. had another tough week. In addition to Kennedy having rotator cuff surgery, the nomination of his ally to become surgeon general is teetering, the controversial head of the FDA's vaccine center is resigning next month, and a new survey shows Americans trust government health officials less than they do former Biden official Anthony Fauci. Anna Edney of Bloomberg News, Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico Magazine, and Shefali Luthra of The 19th join KFF Health News’ Julie Rovner to discuss these stories and more.
A top GOP pollster has said anti-vaccine policies could create risks for the Trump administration in the midterm elections. But backing away from those policies — and other initiatives that have been high on the Make America Healthy Again to-do list — threatens to upset a key voting bloc.
Dentists, hygienists, and researchers say a shortage of rural dental care professionals and worsening oral hygiene since the covid-19 pandemic mean more kids are ending up in the emergency room for tooth decay.
Scientists are cheering California Gov. Gavin Newsom as he builds a public health bulwark against health secretary Robert F. Kennedy Jr.’s anti-vaccine stance and President Donald Trump’s withdrawal from the World Health Organization. Still, federal cuts have sapped morale and left local health departments less prepared for outbreaks.
Get our weekly newsletter, The Week in Brief, featuring a roundup of our original coverage, Fridays at 2 p.m. ET.
Government data shows the National Institutes of Health lost about 4,400 people — more than 20% of its staff — as the Trump administration slashed the federal workforce. Hear from six scientists on why they walked out the door and the work they left behind.
A year after Sen. Bill Cassidy, a Louisiana Republican, warily cast the vote ensuring Robert F. Kennedy Jr.’s ascension to Health and Human Services secretary, his life’s work — in medicine and in politics — is unraveling.
Robert F. Kennedy Jr. has criticized the broadening use of anxiety medications, claiming they’re harmful. Doctors and researchers say the MAHA movement is misrepresenting drugs that have been proved to safely treat chronic anxiety and point to broader social changes to explain their increased use.
The twists and turns continue at the nation’s health agency, where this week’s announcements included notice that the FDA will review Moderna’s new flu vaccine after all and that a handful of top agency officials are getting new jobs. Those developments and others can be traced to a White House looking to shake things up before the midterms — and win over voters on health care. Tami Luhby of CNN, Shefali Luthra of The 19th, and Lauren Weber of The Washington Post join KFF Health News’ Mary Agnes Carey to discuss these stories and more.
Before being confirmed to lead the Department of Health and Human Services, Robert F. Kennedy Jr. told U.S. senators he would not cut funding for vaccine research or change the nation’s official vaccine recommendations. He did both.
Sweeping changes to the Affordable Care Act marketplace next year have been proposed by the Trump administration that focus on making more insurance plans available with higher annual out-of-pocket costs but lower premiums.
Republicans have said new rules requiring many Medicaid participants to work 80 hours a month will pinpoint unemployed young people who should have jobs. Policy researchers say the rules are more likely to disrupt coverage for middle-aged adults, harming their physical and financial health.
At a January event organized by allies of health secretary Robert F. Kennedy Jr., National Cancer Institute Director Anthony Letai said results may be released “in a few months.” Ivermectin, used to deworm horses and other animals, has become a symbol of resistance against the medical establishment among supporters of Kennedy’s “Make America Healthy Again” agenda and many conservatives.
With fractures emerging in the Make America Great Again movement, some Republicans are looking to capitalize on its “MAHA” counterpart ahead of the midterms.
Congress has passed — and President Trump has signed — the annual spending bill for the Department of Health and Human Services. But it’s unclear whether the administration will spend the money as Congress directed. Anna Edney of Bloomberg News, Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico Magazine, and Sandhya Raman of CQ Roll Call join KFF Health News’ Julie Rovner to discuss that story and more. Also this week, Rovner interviews KFF Health News’ Renuka Rayasam about a new reporting project, “Priced Out.”
The Trump administration has made the future of federal funding for cancer research uncertain. At one groundbreaking breast cancer research lab, work that could save lives has slowed significantly.
Get our weekly newsletter, The Week in Brief, featuring a roundup of our original coverage, Fridays at 2 p.m. ET.
The Trump administration’s immigration crackdown is not just roiling politics but also directly affecting the provision of health care, medical groups say. Meanwhile, in Washington, federal spending bills have been stalled by the fight over immigration enforcement funding after the shooting death of a second person in Minneapolis this month. Maya Goldman of Axios, Alice Miranda Ollstein of Politico, and Rachel Roubein of The Washington Post join KFF Health News’ Julie Rovner to discuss those stories and more.
The federal government’s Vaccine Injury Compensation Program was supposed to help patients with their medical bills while protecting vaccine supply. But allies of Health and Human Services Secretary Robert F. Kennedy Jr. are routinely transferring cases from that program to launch lawsuits against drugmakers.
© 2026 KFF